{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:31:47Z","timestamp":1783643507484,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T23:25:14Z","timestamp":1588548314000},"page":"4209-4218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness"],"prefix":"10.1016","volume":"38","author":[{"given":"Amy","family":"Hawksworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Maeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Dibben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.004_b0005","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2005.07.046","article-title":"A review of vaccine research and development: human acute respiratory infections","volume":"23","author":"Girard","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0264-410X(99)00183-8","article-title":"Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children","volume":"18","author":"Boyce","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0015","first-page":"e52421","article-title":"Influenza virus propagation in embryonated chicken eggs","volume":"97","author":"Brauer","year":"2015","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2020.04.004_b0020","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/213612a0","article-title":"Adaptation and growth characteristics of influenza virus at 25 degrees c","volume":"213","author":"Maassab","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.04.004_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/jcm.23.1.66-72.1986","article-title":"Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine","volume":"23","author":"Clements","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0030","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1016\/j.vaccine.2017.09.058","article-title":"Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells","volume":"35","author":"Forero","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0035","doi-asserted-by":"crossref","first-page":"ofx111","DOI":"10.1093\/ofid\/ofx111","article-title":"Live-attenuated influenza vaccine effectiveness in children from 2009 to 2015\u20132016: a systematic review and meta-analysis","volume":"4","author":"Caspard","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.004_b0040","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2094","article-title":"Live attenuated and inactivated influenza vaccine effectiveness","volume":"143","author":"Chung","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2020.04.004_b0045","doi-asserted-by":"crossref","first-page":"e1003831","DOI":"10.1371\/journal.ppat.1003831","article-title":"A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity","volume":"10","author":"Cotter","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2020.04.004_b0050","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1016\/j.vaccine.2016.08.079","article-title":"Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0055","unstructured":"CDC. Update on status of investigation of reduced LAIV effectiveness; 2017. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2017-02\/influenza-06-bright-and-mallory.pdf [accessed September 21, 2018]."},{"key":"10.1016\/j.vaccine.2020.04.004_b0060","unstructured":"CDC. ACIP votes down use of LAIV for 2016\u20132017 flu season; 2016. Available from: https:\/\/www.cdc.gov\/media\/releases\/2016\/s0622-laiv-flu.html [accessed September 21, 2018]."},{"key":"10.1016\/j.vaccine.2020.04.004_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2013 United States, 2017\u201318 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2020.04.004_b0070","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2019.06.016","article-title":"Haemagglutinin stability was not the primary cause of the reduced effectiveness of live attenuated influenza vaccine against A\/H1N1pdm09 viruses in 2013 to 2015","volume":"37","author":"Parker","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0075","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/21645515.2015.1086047","article-title":"Influenza: can we cope better with the unpredictable?","volume":"12","author":"Dos Santos","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.04.004_b0080","doi-asserted-by":"crossref","first-page":"30346","DOI":"10.2807\/1560-7917.ES.2016.21.38.30346","article-title":"Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds \u2013 a nationwide cohort study Finland, influenza season 2015\/16","volume":"21","author":"Nohynek","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.04.004_b0085","doi-asserted-by":"crossref","first-page":"e183742","DOI":"10.1001\/jamanetworkopen.2018.3742","article-title":"Association of prior vaccination with influenza vaccine effectiveness in children receiving live attenuated or inactivated vaccine","volume":"1","author":"McLean","year":"2018","journal-title":"JAMA Net Open"},{"key":"10.1016\/j.vaccine.2020.04.004_b0090","doi-asserted-by":"crossref","first-page":"30394","DOI":"10.2807\/1560-7917.ES.2016.21.45.30394","article-title":"Letter to the editor: Potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines","volume":"21","author":"Ambrose","year":"2016","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2020.04.004_b0095","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.vaccine.2008.11.093","article-title":"Efficacy of live attenuated influenza vaccine in children: a meta-analysis of nine randomized clinical trials","volume":"27","author":"Rhorer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0100","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.vaccine.2011.11.104","article-title":"The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies","volume":"30","author":"Ambrose","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0105","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.vaccine.2015.11.010","article-title":"Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2\u201317 years of age in 2013\u20132014 in the United States","volume":"34","author":"Caspard","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0110","first-page":"e50646","article-title":"Culturing of human nasal epithelial cells at the air liquid interface","volume":"80","author":"M\u00fcller","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.vaccine.2020.04.004_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2013.06.031","article-title":"Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro","volume":"446","author":"Tapparel","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.04.004_b0120","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1016\/j.vaccine.2015.07.023","article-title":"Restricted replication of the live attenuated influenza A virus vaccine during infection of primary differentiated human nasal epithelial cells","volume":"33","author":"Fischer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0125","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1128\/JVI.79.11.6763-6771.2005","article-title":"Improvement of influenza A\/Fujian\/411\/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics","volume":"79","author":"Lu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0130","first-page":"5","article-title":"A simple method of estimation fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hygiene"},{"key":"10.1016\/j.vaccine.2020.04.004_b0135","series-title":"Handbook of biological statistics","author":"McDonald","year":"2014"},{"key":"10.1016\/j.vaccine.2020.04.004_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02123572","article-title":"Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin","volume":"162","author":"Tobita","year":"1975","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jviromet.2004.03.011","article-title":"Comparative study of influenza virus replication in Vero and MDCK cell lines","volume":"120","author":"Youil","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.04.004_b0150","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.virol.2014.08.007","article-title":"Lung epithelial cells resist influenza A infection by inducing the expression of cytochrome c oxidase VIc which is modulated by miRNA 4276","volume":"468\u2013470","author":"Othumpangat","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.04.004_b0155","doi-asserted-by":"crossref","first-page":"11725","DOI":"10.1128\/JVI.01477-12","article-title":"Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium","volume":"86","author":"Ilyushina","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00441-010-1043-z","article-title":"Respiratory epithelial cells in innate immunity to influenza virus infection","volume":"343","author":"Sanders","year":"2011","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.vaccine.2020.04.004_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/aivt.2016.0028","article-title":"The use of human 3D reconstructed airway cultures for tobacco product evaluation: precision low-volume exposures at the apical site","volume":"3","author":"Behrsing","year":"2017","journal-title":"Appl In Vitro Toxicol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0170","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.vaccine.2013.12.069","article-title":"Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures","volume":"32","author":"Fischer","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.004_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2015.01.007","article-title":"Functions of the influenza A virus NS1 protein in antiviral defense","volume":"12","author":"Krug","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/v9100269","article-title":"Live attenuated influenza vaccine contains substantial and unexpected amounts of defective viral genomic RNA","volume":"9","author":"Gould","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2020.04.004_b0185","series-title":"Poster presented at negative strand RNA virus meeting","article-title":"Defective interfering vRNA are present in live attenuated influenza vaccine but they are not a majority population and do not appear to drive reduced vaccine effectiveness","author":"Ayaz","year":"2018"},{"key":"10.1016\/j.vaccine.2020.04.004_b0190","doi-asserted-by":"crossref","first-page":"6015","DOI":"10.1128\/JVI.74.13.6015-6020.2000","article-title":"Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus","volume":"74","author":"Mitnaul","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.04.004_b0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/INF.0b013e31819219b8","article-title":"Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children","volume":"28","author":"Bracco Neto","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.004_b0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31806166f8","article-title":"Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia","volume":"26","author":"Tam","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.004_b0205","doi-asserted-by":"crossref","unstructured":"Mallory R, Nyborg A, Kalyani R, Yuan Y, Block S, Dubovsky F. A randomized study to evaluate the shedding and immunogenicity of H1N1 strains in trivalent and quadrivalent formulations of flumist in children 24 to <48 months of age. IDWeek 2018. Poster 1954.","DOI":"10.1093\/ofid\/ofy210.1610"},{"key":"10.1016\/j.vaccine.2020.04.004_b0210","doi-asserted-by":"crossref","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) \u2013 United States, 2018\u201319 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.04.004_b0215","unstructured":"Public Health England. Influenza vaccine effectiveness (VE) in adults and children in primary care in the United Kingdom (UK): provisional end-of season results 2017\u201318. 2018. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/726342\/Influenza_vaccine_effectiveness_in_primary_care_2017_2018.pdf [accessed September 21, 2018]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030462X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030462X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:29Z","timestamp":1759401809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030462X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":43,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X2030462X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication of live attenuated influenza vaccine viruses in human nasal epithelial cells is associated with H1N1 vaccine effectiveness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}